| 000 | 01655 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516060320.0 | ||
| 264 | 0 | _c20120329 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1872-7913 | ||
| 024 | 7 |
_a10.1016/j.ijantimicag.2011.08.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSonnet, Pascal | |
| 245 | 0 | 0 |
_aPrevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cJan 2012 |
||
| 300 |
_a77-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 |
_aDipeptides _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLevofloxacin |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aOfloxacin _xpharmacology |
| 650 | 0 | 4 | _aPiperazine |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aPseudomonas Infections _xepidemiology |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 700 | 1 | _aIzard, Daniel | |
| 700 | 1 | _aMullié, Catherine | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 39 _gno. 1 _gp. 77-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijantimicag.2011.08.005 _zAvailable from publisher's website |
| 999 |
_c21209614 _d21209614 |
||